|
[1] MACK CL,ADAMS D,ASSIS DN,et al. Diagnosis and management of autoimmune hepatitis in adults and children:2019practice guidance and guidelines from the American Association for the study of liver diseases[J]. Hepatology,2019.[Epub ahead of print]
|
|
[2] WASHINGTON MK. Autoimmune liver disease:Overlap and outliers[J]. Mod Pathol,2007,20(Suppl 1):s15-s30.
|
|
[3] GUINDI M. Histology of autoimmune hepatitis and its variants[J]. Clin Liver Dis,2010,14(4):577-590.
|
|
[4] GLEESON D,HENEGHAN MA,British Society of Gastroenterology. British Society of Gastroenterology(BSG)guidelines for management of autoimmune hepatitis[J]. Gut,2011,60(12):1611-1629.
|
|
[5] BALITZER D,SHAFIZADEH N,PETERS MG,et al. Autoimmune hepatitis:Review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria[J].Mod Pathol,2017,30(5):773-783.
|
|
[6] MIAO Q,BIAN Z,TANG R,et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis[J]. Clin Rev Allergy Immunol,2015,48(2-3):226-235.
|
|
[7] KLEINER DE,CHALASANI NP,LEE WM,et al. Hepatic histological findings in suspected drug-induced liver injury:Systematic evaluation and clinical associations[J]. Hepatology,2014,59(2):661-670.
|
|
[8] STRAVITZ RT,LEFKOWITCH JH,FONTANA RJ,et al. Autoimmune acute liver failure:Proposed clinical and histological criteria[J]. Hepatology,2011,53(2):517-526.
|
|
[9] TAKAHASHI A,ARINAGA-HINO T,OHIRA H,et al. Autoimmune hepatitis in Japan:Trends in a nationwide survey[J]. J Gastroenterol,2017,52(5):631-640.
|
|
[10] ZEN Y,NOTSUMATA K,TANAKA N,et al. Hepatic centrilobular zonal necrosis with positive antinuclear antibody:A unique subtype or early disease of autoimmune hepatitis?[J]. Hum Pathol,2007,38(11):1669-1675.
|
|
[11] AIZAWA Y,ABE H,SUGITA T,et al. Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis[J]. Eur J Gastroenterol Hepatol,2016,28(4):391-397.
|
|
[12] MEHENDIRATTA V,MITROO P,BOMBONATI A,et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2009,7(1):98-103.
|
|
[13] CHAZOUILLRES O,WENDUM D,SERFATY L,et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:Clinical features and response to therapy[J]. Hepatology,1998,28(2):296-301.
|
|
[14] NAKANUMA Y,ISHIZU Y,ZEN Y,et al. Histopathology of IgG4-related autoimmune hepatitis and IgG4-related hepatopathy in IgG4-related disease[J]. Semin Liver Dis,2016,36(3):229-241.
|
|
[15] ALVAREZ F,BERG PA,BIANCHI FB,et al. International Autoimmune Hepatitis Group Report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.
|
|
[16] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.
|
|
[17] QIU D,WANG Q,WANG H,et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients[J]. J Hepatol,2011,54(2):340-347.
|
|
[18] GURUNG A,ASSIS DN,MCCARTY TR,et al. Histologic features of autoimmune hepatitis:A critical appraisal[J]. Hum Pathol,2018,82:51-60.
|
|
[19] DELEMOS AS,FOUREAU DM,JACOBS C,et al. Drug-induced liver injury with autoimmune features[J]. Semin Liver Dis,2014,34(2):194-204.
|
|
[20] SUZUKI A,BRUNT EM,KLEINER DE,et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury[J]. Hepatology,2011,54(3):931-939.
|
|
[21] HARADA K,HIEP NC,OHIRA H. Challenges and difficulties in pathological diagnosis of autoimmune hepatitis[J]. Hepatol Res,2017,47(10):963-971.
|
|
[22] GONZALEZ RS,WASHINGTON K. Primary biliary cholangitis and autoimmune hepatitis[J]. Surg Pathol Clin,2018,11(2):329-349.
|
|
[23] DHALIWAL HK,HOEROLDT BS,DUBE AK,et al. Longterm prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis[J].Am J Gastroenterol,2015,110(7):993-999.
|
DownLoad: